• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软脑膜癌病诊断的新突破:脑脊液液体活检综述

New Breakthroughs in the Diagnosis of Leptomeningeal Carcinomatosis: A Review of Liquid Biopsies of Cerebrospinal Fluid.

作者信息

Goldberg Maria, Mondragon-Soto Michel G, Altawalbeh Ghaith, Meyer Bernhard, Aftahy Amir Kaywan

机构信息

Department of Neurosurgery, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, DEU.

Neurological Surgery, Instituto Nacional de Neurologia y Neurocirugia, Mexico, MEX.

出版信息

Cureus. 2024 Feb 28;16(2):e55187. doi: 10.7759/cureus.55187. eCollection 2024 Feb.

DOI:10.7759/cureus.55187
PMID:38558729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10980855/
Abstract

Leptomeningeal carcinomatosis represents a terminal stage and is a devastating complication of cancer. Despite its high incidence, current diagnostic methods fail to accurately detect this condition in a timely manner. This failure to diagnose leads to the refusal of treatment and the absence of clinical trials, hampering the development of new therapy strategies. The use of liquid biopsy is revolutionizing the field of diagnostic oncology. The dynamic and non-invasive detection of tumor markers has enormous potential in cancer diagnostics and treatment. Leptomeningeal carcinomatosis is a condition where invasive tissue biopsy is not part of the routine diagnostic analysis, making liquid biopsy an essential diagnostic tool. Several elements in cerebrospinal fluid (CSF) have been investigated as potential targets of liquid biopsy, including free circulating tumor cells, free circulating nucleic acids, proteins, exosomes, and even non-tumor cells as part of the dynamic tumor microenvironment. This review aims to summarize current breakthroughs in the research on liquid biopsy, including the latest breakthroughs in the identification of tumor cells and nucleic acids, and give an overview of future directions in the diagnosis of leptomeningeal carcinomatosis.

摘要

软脑膜癌病是癌症的终末期,也是一种毁灭性的并发症。尽管其发病率很高,但目前的诊断方法无法及时准确地检测出这种疾病。这种诊断失败导致治疗被拒绝且缺乏临床试验,阻碍了新治疗策略的发展。液体活检的应用正在彻底改变诊断肿瘤学领域。肿瘤标志物的动态和非侵入性检测在癌症诊断和治疗中具有巨大潜力。软脑膜癌病是一种侵袭性组织活检并非常规诊断分析一部分的疾病,这使得液体活检成为一种重要的诊断工具。脑脊液(CSF)中的几种成分已被研究作为液体活检的潜在靶点,包括游离循环肿瘤细胞、游离循环核酸、蛋白质、外泌体,甚至作为动态肿瘤微环境一部分的非肿瘤细胞。本综述旨在总结液体活检研究的当前突破,包括肿瘤细胞和核酸鉴定方面的最新突破,并概述软脑膜癌病诊断的未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcc/10980855/130eacaca570/cureus-0016-00000055187-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcc/10980855/c01fe74f8db3/cureus-0016-00000055187-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcc/10980855/130eacaca570/cureus-0016-00000055187-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcc/10980855/c01fe74f8db3/cureus-0016-00000055187-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcc/10980855/130eacaca570/cureus-0016-00000055187-i02.jpg

相似文献

1
New Breakthroughs in the Diagnosis of Leptomeningeal Carcinomatosis: A Review of Liquid Biopsies of Cerebrospinal Fluid.软脑膜癌病诊断的新突破:脑脊液液体活检综述
Cureus. 2024 Feb 28;16(2):e55187. doi: 10.7759/cureus.55187. eCollection 2024 Feb.
2
Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.检测乳腺癌患者脑脊液中的非整倍体可提高软脑膜转移的诊断率。
Clin Cancer Res. 2021 May 15;27(10):2798-2806. doi: 10.1158/1078-0432.CCR-20-3954. Epub 2021 Jan 29.
3
Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis.通过对合并脑膜转移的非小细胞肺癌的蛋白质组学分析发现脑脊液外泌体蛋白改变。
J Neurooncol. 2023 Sep;164(2):367-376. doi: 10.1007/s11060-023-04428-x. Epub 2023 Sep 1.
4
Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis.液体活检在脑膜转移中的应用:系统评价和荟萃分析。
J Neurooncol. 2023 Dec;165(3):431-438. doi: 10.1007/s11060-023-04519-9. Epub 2023 Nov 29.
5
Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers.液体活检作为精准医学中的新型工具:癌症生物标志物的起源、特性、识别及临床前景
Diagnostics (Basel). 2020 Apr 13;10(4):215. doi: 10.3390/diagnostics10040215.
6
The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.脑脊液中癌胚抗原(CEA)与循环肿瘤DNA(ctDNA)的联合检测:癌症软脑膜转移诊断的辅助工具
J Cancer Res Clin Oncol. 2023 May;149(5):1679-1690. doi: 10.1007/s00432-022-04053-7. Epub 2022 May 18.
7
Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report.一名乳腺癌患者中类似柔脑膜癌病的神经莱姆病:病例报告
J Investig Med High Impact Case Rep. 2014 Mar 28;2(1):2324709614529417. doi: 10.1177/2324709614529417. eCollection 2014 Jan-Mar.
8
Rare case of pancreatic cancer with leptomeningeal carcinomatosis.罕见的胰腺癌伴软脑膜癌病病例。
World J Gastroenterol. 2015 Jan 21;21(3):1020-3. doi: 10.3748/wjg.v21.i3.1020.
9
New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo.体外和体内循环肿瘤标志物在脑脊液诊断和治疗中的新前沿。
Cells. 2019 Oct 2;8(10):1195. doi: 10.3390/cells8101195.
10
Applications of cerebrospinal fluid circulating tumor cells and circulating tumor-derived DNA in diagnosis, prognosis, and personalized treatment of CNS metastases.脑脊液循环肿瘤细胞和循环肿瘤衍生DNA在中枢神经系统转移瘤诊断、预后及个性化治疗中的应用
Front Oncol. 2024 Sep 30;14:1409383. doi: 10.3389/fonc.2024.1409383. eCollection 2024.

本文引用的文献

1
Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma.脑脊液人附睾蛋白 4 对肺腺癌脑膜转移的诊断价值。
Front Immunol. 2024 Jan 18;15:1339914. doi: 10.3389/fimmu.2024.1339914. eCollection 2024.
2
Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.脑脊髓液转移瘤:EANO-ESMO 诊断、治疗和随访的临床实践指南
ESMO Open. 2023 Oct;8(5):101624. doi: 10.1016/j.esmoop.2023.101624. Epub 2023 Sep 19.
3
Advances on Liquid Biopsy Analysis for Glioma Diagnosis.
用于神经胶质瘤诊断的液体活检分析进展
Biomedicines. 2023 Aug 24;11(9):2371. doi: 10.3390/biomedicines11092371.
4
Cerebrospinal fluid exosomal protein alterations via proteomic analysis of NSCLC with leptomeningeal carcinomatosis.通过对合并脑膜转移的非小细胞肺癌的蛋白质组学分析发现脑脊液外泌体蛋白改变。
J Neurooncol. 2023 Sep;164(2):367-376. doi: 10.1007/s11060-023-04428-x. Epub 2023 Sep 1.
5
Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.脑膜转移癌常见突变基因的荟萃分析。
PeerJ. 2023 Apr 19;11:e15250. doi: 10.7717/peerj.15250. eCollection 2023.
6
High-dimensional immune cell profiling of cerebrospinal fluid from patients with metastatic breast cancer and leptomeningeal disease.转移性乳腺癌和柔脑膜疾病患者脑脊液的高维免疫细胞分析
NPJ Breast Cancer. 2023 Apr 7;9(1):22. doi: 10.1038/s41523-023-00526-1.
7
Diagnostic accuracy of cerebrospinal fluid liquid biopsy and MRI for leptomeningeal metastases in solid cancers: A systematic review and meta-analysis.脑脊液液体活检和磁共振成像对实体癌软脑膜转移的诊断准确性:一项系统评价和荟萃分析
Neurooncol Adv. 2023 Mar 5;5(1):vdad002. doi: 10.1093/noajnl/vdad002. eCollection 2023 Jan-Dec.
8
Quantitative protein biomarker panels: a path to improved clinical practice through proteomics.定量蛋白质生物标志物面板:通过蛋白质组学改善临床实践的途径。
EMBO Mol Med. 2023 Apr 11;15(4):e16061. doi: 10.15252/emmm.202216061. Epub 2023 Mar 20.
9
Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases.脑脊液外泌体 microRNAs 作为非小细胞肺癌伴脑膜转移的诊断或监测进展的生物标志物。
Biotechnol Genet Eng Rev. 2024 Apr;40(1):359-380. doi: 10.1080/02648725.2023.2183613. Epub 2023 Feb 28.
10
Identification of risk factors associated with leptomeningeal disease after resection of brain metastases.识别与脑转移瘤切除术后脑膜疾病相关的风险因素。
J Neurosurg. 2023 Jan 13;139(2):402-413. doi: 10.3171/2022.12.JNS221490. Print 2023 Aug 1.